Hallux Valgus and Bunion
0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Nordic PharmaFrance - Paris
1 programMinimally invasive lapidus procedure with no arthroscopyN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
2027
CalicoAnalgesic Non Narcotic
Nordic PharmaMinimally invasive lapidus procedure with no arthroscopy
Clinical Trials (2)
Total enrollment: 58 patients across 2 trials
Post-Operative Pain and Opioid Reduction Trial After Bunionectomy
Start: Jun 2022Est. completion: Nov 2022
Phase 2Completed
Prospective Study of Minimally Invasive Lapidus Procedure for Hallux Valgus Deformities
Start: Oct 2024Est. completion: May 202758 patients
N/ANot Yet Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.